~(35)S 标记抗人肝癌单克隆抗体Hepama-1的制备

  • 摘要: 采用H235SO4与苯胺合成35S-苯胺硫酸盐,经高温转换成35S-对氨基苯磺酸,然后再用碳二亚胺交联到抗人肝癌单克隆抗体Hepama-1上。所得35S-MAbHepama-1用Elisa方法检测仍保持良好的免疫活性。产品最高比活度可达51.8GBq/g,放化纯度>95%,放化产率以H235SO4投料计算最高可达27%,以35S-对氨基苯磺酸投料计算最高可达45%,适用于做荷瘤裸鼠动物模型放免治疗研究实验。

     

    Abstract: PREPARATION OF 35SMAb HEPAMA1Zhou Zhentang\ Zhuang Daoling\ Wu Yuanfang\ Zhang YulongHe Zhanjun\ Liu Guanfu\ Yao Fuzeng(Shanghai Institute of Nuclear Research, the Chinese Academy of Sciences, 201800)ABSTRACTMonoclonal antibody Hepama1(MAb Hepama1) against human hepatoma is labelled with 35S by the carbodiimine method. The 35Ssulfanilic acid is transferred from 35Saniline sulfate which is synthesized by both H235SO4 and aniline, and then, it is connected to the MAb Hepama1. The resultant labelled MAb Hepama1 retains immunoreactivity and had a maximum specific activity of 51.8 GBq/g and a radiochemical purity of >95%. The radiochemical yield are 27% and 45%, according to the primary activity of H235SO4 and 35Ssulfanilic acid respectively. It is used as a radioimmunotherapy agent with a strong cytotoxic and tumorinhibitory effect in the Hepamabearing nude mice.Key words 35S monoclonal antibody Hepama1 against human hepatoma 35SMAb Hepama1 preparation

     

/

返回文章
返回